Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
4,580
-270
-6% -$95.9K 0.89% 37
2026
Q1
$1.4M Buy
4,850
+1,320
+37% +$366K 0.73% 38
2025
Q4
$901K Buy
3,530
+215
+6% +$57.8K 0.45% 47
2025
Q3
$1.07M Buy
3,315
+1,800
+119% +$563K 0.53% 46
2025
Q2
$446K Buy
1,515
+200
+15% +$55.3K 0.24% 59
2025
Q1
$350K Buy
1,315
+75
+6% +$21K 0.2% 65
2024
Q4
$312K Buy
1,240
+200
+19% +$47.8K 0.17% 68
2024
Q3
$229K Buy
+1,040
New +$202K 0.12% 80
2014
Q3
Sell
-46,785
Closed -$5.21M 63
2014
Q2
$5.21M Buy
46,785
+150
+0.3% +$16.1K 3.28% 10
2014
Q1
$4.73M Sell
46,635
-2,645
-5% -$280K 3.16% 16
2013
Q4
$4.48M Buy
49,280
+510
+1% +$43.4K 3.06% 17
2013
Q3
$4.18M Buy
48,770
+3,925
+9% +$334K 3.07% 18
2013
Q2
$3.09M Buy
+44,845
New +$3.45M 2.56% 22

Other funds holding FFIV

Lipe & Dalton's FFIV Position: Q2 2026 in Review

Lipe & Dalton reduced its F5 (FFIV) stake by 5.6% in Q2 2026, selling an estimated $95.9K and leaving 4,580 shares worth $1.91M. The position accounts for 0.89% of the portfolio, ranked #37.

Lipe & Dalton first reported a position in FFIV in Q2 2013 and has held it in 13 quarters since. The position peaked at $5.21M in Q2 2014. 827 funds tracked by Wall St. Rank hold FFIV as of Q2 2026.

  • Lipe & Dalton held 4,580 shares of F5 worth $1.91M as of Q2 2026.
  • Lipe & Dalton sold 270 F5 shares in Q2 2026, an estimated $95.9K.
  • F5 made up 0.89% of Lipe & Dalton's portfolio in Q2 2026, its #37 holding.
  • Lipe & Dalton first reported a position in F5 in Q2 2013 and has held it in 13 quarters since.
  • Lipe & Dalton's F5 position peaked at $5.21M in Q2 2014.
  • 827 funds tracked by Wall St. Rank held F5 as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.